MedPath

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

Phase 2
Recruiting
Conditions
Primary Biliary Cholangitis
PBC
Interventions
Drug: Placebo
Registration Number
NCT05050136
Lead Sponsor
Mirum Pharmaceuticals, Inc.
Brief Summary

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Provide signed informed consent at the screening visit as well as comply with all study visits and requirements through the end of the study
  • Male or female, age ≥18 years at the screening visit
  • Confirmed diagnosis of PBC in line with the AASLD guidelines
  • UDCA and anti-pruritic medication use will be allowed if meeting additional criteria
  • Qualified pruritus associated with PBC as assessed by Adult ItchRO
Exclusion Criteria
  • Pruritus associated with an etiology other than PBC
  • Evidence or clinical suspicion of decompensated cirrhosis or a history of decompensation events
  • Current symptomatic cholelithiasis or inflammatory gallbladder disease
  • History of small bowel surgery/resection impacting the terminal ileum that may disrupt the enterohepatic circulation.
  • Evidence, history, or suspicion of other liver diseases; PBC patients with AIH are not excluded
  • History of Liver transplantation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Part 1 Arm 1: Volixibat 20mgVolixibatParticipants randomized to this arm will receive volixibat 20mg twice daily.
Part 1 Arm 2: Volixibat 80mgVolixibatParticipants randomized to this arm will receive volixibat 80mg twice daily.
Part 1 Arm 3: PlaceboPlaceboParticipants in this arm will receive capsules matched to the study drug minus the active volixibat substance, twice daily.
Part 2 Arm 1: Volixibat Selected Dose 20mgVolixibatParticipants randomized to this arm will receive volixibat 20mg twice daily.
Part 2 Arm 2: PlaceboPlaceboParticipants in this arm will receive capsules matched to the study drug minus the active volixibat substance, twice daily.
Primary Outcome Measures
NameTimeMethod
Mean change in the daily itch scores using the Adult Itch Reported Outcome (Adult ItchRO) questionnaireBaseline to week 28

The Adult ItchRO is an 11-point NRS measurement of itch severity ranging from 0=no itch to 10=worst possible itch.

Secondary Outcome Measures
NameTimeMethod
Incidence of adverse eventsBaseline to week 28
Changes in alkaline phosphataseBaseline to week 28
Changes in total bilirubinBaseline to week 28
Proportion of participants with itch response using the Adult ItchROBaseline to week 28
Changes in serum bile acid levelsBaseline to week 28
Change in Primary Biliary Cholangitis Quality of Life Measure (PBC-40)Baseline to week 28

PBC-40 questionnaire is scored on a scale of 40 to 200, with higher scores indicating poorer quality of life

Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) fatigue questionnaireBaseline to week 28

The PROMIS® Fatigue questionnaire is a 5-point response scale. Respondents endorse each item using a 5-point response scale: Never, Rarely, Sometimes, Often, and Always.

Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) sleep disturbance questionnaireBaseline to week 28

The PROMIS® Sleep Disturbance in an 8-item measure that assesses quality of sleep, sleep depth, and restoration associated with sleep. It is a 5-point response scale, the specific response options vary by items. The first 4 items use response options that range from Not at all to Very much. The next 3 items use response options that range from Never to Always. The final item assesses sleep quality ranging from Very poor to Very good.

Trial Locations

Locations (91)

Southern California Research Center

🇺🇸

Coronado, California, United States

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

University of Colorado

🇺🇸

Aurora, Colorado, United States

Covenant Metabolic Specialists

🇺🇸

Fort Myers, Florida, United States

UF Hepatology Research at CTRB

🇺🇸

Gainesville, Florida, United States

UF Health Gastroenterology- Emerson

🇺🇸

Jacksonville, Florida, United States

IHS Health

🇺🇸

Kissimmee, Florida, United States

Schiff Center for Liver Diseases

🇺🇸

Miami, Florida, United States

Advanced Research Institute, Inc

🇺🇸

New Port Richey, Florida, United States

Covenant Research and Clinics, LLC

🇺🇸

Sarasota, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

Southeast Clinical Research Center

🇺🇸

Dalton, Georgia, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

Loyola University Health System - Loyola Outpatient Center

🇺🇸

Maywood, Illinois, United States

University of Iowa Hospitals & Clinics

🇺🇸

Iowa City, Iowa, United States

Ochsner Clinic Foundation-Baton Rouge

🇺🇸

Baton Rouge, Louisiana, United States

LSU Health Science Center Shreveport

🇺🇸

Shreveport, Louisiana, United States

Beth Israel Deaconess

🇺🇸

Boston, Massachusetts, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Jackson Liver and GI Specialists

🇺🇸

Jackson, Mississippi, United States

CHI Health Clinic (Alegent Creighton Clinic)- Gastroenterology-Bergan

🇺🇸

Omaha, Nebraska, United States

Science 37, Inc (Remote-homebased Telemedicine)

🇺🇸

Morrisville, North Carolina, United States

Cleveland Clinic - Main Campus

🇺🇸

Cleveland, Ohio, United States

Einstein Healthcare Network - Einstein Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

Methodist Le Bonheur Healthcare

🇺🇸

Memphis, Tennessee, United States

Galen Medical Group, P.C

🇺🇸

Tennessee, Tennessee, United States

Amel Med LLC

🇺🇸

Austin, Texas, United States

Soma Clinical Trials

🇺🇸

Denison, Texas, United States

Liver Associates of Texas

🇺🇸

Houston, Texas, United States

Velocity Clinical Research

🇺🇸

Waco, Texas, United States

University of Utah Health Care

🇺🇸

Salt Lake City, Utah, United States

MedStar Health Research Institute

🇺🇸

Fairfax, Virginia, United States

Bon Secours Liver Institute of Hampton Roads Mary Immaculate Hospital

🇺🇸

Newport News, Virginia, United States

Bon Secours Richmond Community Hospital LLC d/b/a Bon Secours Liver Institute of Richmond

🇺🇸

Richmond, Virginia, United States

Liver Institute Northwest

🇺🇸

Seattle, Washington, United States

Hospital de Alta Complejidad En Red El Cruce

🇦🇷

Florencio Varela, Buenos Aires, Argentina

Glenny Corp S.A

🇦🇷

Caba, Argentina

Universitair Ziekenhuis Antwerpe UZA

🇧🇪

Antwerp, Belgium

Cliniques Universitaires Saint-Luc

🇧🇪

Brussel, Belgium

UZ Gent

🇧🇪

Gent, Belgium

Centro de Pesquisa Clínica da Bahiana Saúde

🇧🇷

Salvador, Bahia, Brazil

Centro de Pesquisas Clínicas do HC/UFMG-EBSERH

🇧🇷

Belo Horizonte, Minas Gerais, Brazil

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, RS, Brazil

Fundação Oswaldo Ramos

🇧🇷

São Paulo, Brazil

Gordon and Leslie Diamond Health Care Centre, Division of Gastroenterology

🇨🇦

Vancouver, British Columbia, Canada

University Hospital, LHSC

🇨🇦

London, Ontario, Canada

University of Alberta

🇨🇦

Edmonton, Canada

CHU Grenoble - Hôpital MICHALLON

🇫🇷

Grenoble, France

Hopital Claude Huriez-Digestive system disease clinic

🇫🇷

Lille, France

CHU de NICE- Hospital L'Archet 2

🇫🇷

Nice, France

Hospital Saint Antoine

🇫🇷

Paris, France

Nouvel Hospital Civil

🇫🇷

Strasbourg, France

Hospital Paul Brousse- APHP

🇫🇷

Villejuif, France

Klinikum Chemnitz gGmbH

🇩🇪

Chemnitz, Germany

Universitätsklinikum Frankfurt am Main

🇩🇪

Frankfurt, Germany

Medizinische Hochschule Hannover (MHH)

🇩🇪

Hanover, Germany

Universitätsklinikum Schleswig-Holstein

🇩🇪

Kiel, Germany

University Hospital Munster

🇩🇪

Münster, Germany

University Hospital Tübingen Medical clinic

🇩🇪

Tubingen, Germany

St. Josefs-Hospital Wiesbaden

🇩🇪

Wiesbaden, Germany

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

Rambam Medical Center

🇮🇱

Haifa, Israel

Carmel Medical Center

🇮🇱

Haifa, Israel

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

Hadassah Medical Center - Ein Karem, Liver Institute Kiryat Hadassah POB 12000

🇮🇱

Jerusalem, Israel

Galilee Medical Center

🇮🇱

Nahariyya, Israel

Rabin Medical Center

🇮🇱

Petach Tikva, Israel

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

The Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Universita Politecnica delle Marche- Ospedali Riuniti

🇮🇹

Ancona, Italy

Fondazione Ca Granda

🇮🇹

Milano, Italy

ASST Grande Ospedale Metropolitano Niguarda

🇮🇹

Milano, Italy

Fondazione IRCCS San Gerardo dei Tintori

🇮🇹

Monza, Italy

Azienda Ospedale-Università di Padova

🇮🇹

Padova, Italy

Azienda Ospedaliero Universitaria Pisana (AOUP)

🇮🇹

Pisa, Italy

Istituto Clinico Humanitas

🇮🇹

Rozzano, Italy

National Hospital Organization Nagasaki Medical Center

🇯🇵

Ōmura, Nagasaki, Japan

Ehime University Hospital

🇯🇵

Ehime, Japan

Toranomon Hospital

🇯🇵

Tokyo, Japan

Juntendo University Hospital

🇯🇵

Tokyo, Japan

Amstedam University Medical Centers

🇳🇱

Amsterdam, Netherlands

Radboudumc

🇳🇱

Nijmegen, Netherlands

Erasmus medical center

🇳🇱

Rotterdam, Netherlands

Hospital Clínic de Barcelona

🇪🇸

Barcelona, Spain

Hospital Universitari Parc Tauli

🇪🇸

Barcelona, Spain

Hospital General Universitario Gregorio Maranon

🇪🇸

Madrid, Spain

Hospital Universitario Virgen del Rocio

🇪🇸

Sevilla, Spain

University Hospital Southampton NHS Foundation Trust

🇬🇧

Southampton, Hampshire, United Kingdom

Belfast Health & Social Care Trust (BHSCT) Royal Victoria Hospital

🇬🇧

Belfast, United Kingdom

King's College Hospital NHS Foundation Trust

🇬🇧

London, United Kingdom

Nottingham University Hospitals NHS Trust

🇬🇧

Nottingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath